Bioavailability assessment of arginine-vasopressin (AVP) using pharmacokinetic-pharmacodynamic (PK-PD) modeling in the rat

Biological and Pharmaceutical Bulletin

Volumn 23, Issue 1, 2000, Pages 87-96

  Miyazaki, Makoto ^a   Sawada, Shin Ichi ^a   Nishide, Takayoshi ^a   Iwanaga, Kazunori ^a   Morimoto, Kazuhiro ^b   Kakemi, Masawo ^a  

^a OSAKA MEDICAL COLLEGE   (Japan)

^b HOKKAIDO INSTITUTE OF TECHNOLOGY   (Japan)

Author keywords

Arginine vasopressin (AVP); Bioavailability; Pharmacodynamics; Pharmacokinetics; Pharmacological data; Vasopressin

Indexed keywords

ARGIPRESSIN;

ANIMAL EXPERIMENT; ANTIDIURESIS; ARTICLE; BIOAVAILABILITY; CONTROLLED STUDY; DRUG RECEPTOR BINDING; HEMODYNAMICS; MALE; MEAN ARTERIAL PRESSURE; NONHUMAN; RAT; RECEPTOR AFFINITY; SODIUM URINE LEVEL;

EID: 0033973537     PISSN: 09186158     EISSN: None     Source Type: Journal    
DOI: 10.1248/bpb.23.87     Document Type: Article

References (24)

1. Pitt C. G., Int. J. Pharmaceut., 59, 173-196 (1990).
2. Tomlinson E., Adv. Drug Deliv. Rev., 1, 87-198 (1987).
3. Derendorf H., Möllmann H., Krieg M., Tunn S., Möllmann C., Barth J., Röthig H.-J., Pharm. Res., 8, 263-268 (1991).
4. Wald J. A., Salazar D. E., Cheng H., Jusko W. J., J. Pharmacokinet. Biopharm., 19, 521-536 (1991).
5. Hochhaus G., Derendorf H., "Handbook of Pharmacokinetic/Pharmacodynamic Correlation," ed. by Derendorf H., Hochhaus G., CRC Press Inc., Boca Raton,1995, pp. 79-120.
6. Smolen V. F., J. Pharmacokinet. Biopharm., 4, 337-353 (1976).
7. Smolen V. F., Shoenwald R. D., J. Pharm. Sci., 60, 96-103 (1971).
8. Stagni G., Shepherd A. M. M., Liu Y., Gillespie W. R., J. Pharmacokinet. Biopharm., 25, 349-362 (1997).
9. Veng-Pedersen P., Gillespie W. R., J. Pharm. Sci., 77, 39-47 (1988).
10. Stagni G., Shepherd A. M. M., Liu Y., Gillespie W. R., J. Pharmacokinet. Biopharm., 25, 313-348 (1997).
11. Sato H., Sugiyama Y., Sawada Y., Iga T., Fuwa T., Hanano M., Am. J. Physiol., 258, G682-689 (1990).
12. Lu W., Endoh M., Katayama K., Kakemi M., Koizumi T., J. Phrmacobio-Dyn., 10, 356-363 (1987).
13. Nichols A. I., Boudinot F. D., Jusko W. J., J. Pharmacokinet. Biopharm., 17, 209-227 (1989).
14. Venitz J., "Handbook of Pharmacokinetic/Pharmacodynamic Correlation," ed. by Derendorf H., Hochhaus G., CRC Press Inc., Boca Raton, 1995, pp. 1-34.
15. Janáky T., László F. A., Morgat J.-L., Acta Medica. Hungarica., 41, 43-54 (1984).
16. Matuszewska B., Liversidge G. G., Ryan F., Dent J., Smith P. L., Int. J. Pharmaceut., 46, 111-120 (1988).
17. Fjellestad-Paulsen A., Söderberg-Ahlm C., Lundin S., Peptides, 16, 1141-1147 (1995).
18. Vilhardt H., Lundin S., Acta Physiol. Scand., 126, 601-607 (1986).
19. Michell R. H., Kirk C. J., Billah M. M., Biochem. Soc. Trans., 7, 861-865 (1979).
20. Jard S., Curr. Top. Membr. Transp., 18, 255-285 (1983).
21. Stassen F. L., Heckman G., Schmidt D., Aiyar N., Nambi P., Crooke S. T., Mol. Pharmacol., 31, 259-266 (1987).
22. Hertel C., Perkins J. P., Mol. Cell. Endocrinol., 37, 245-256 (1984).
23. Chang P., Kimura K., Biochem. Biophys. Res. Commun., 144, 770-778 (1987).
24. Dublineau I., Pradelles P., de Rouffignac C., Elalouf J.-M., Ren. Physiol. Biochem., 15, 57-65 (1992).